본문 바로가기
KERD
논문KCI 등재

TNFα Induces Multidrug Resistance-Associated Protein 4 Expression through p38-E2F1-Nrf2 Signaling in Obstructive Cholestasis

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류의학일반

초록

Purpose: To explore the molecular mechanism of the upregulation of multidrug resistance-associated protein 4 (MRP4) in cholestasis. Materials and Methods: The mRNA and protein levels of MRP4 in liver samples from cholestatic patients were determined byquantitative real-time PCR and Western blot. In human hepatoma HepG2 cells, electrophoretic mobility shift assay (EMSA) wasused to determine the affinity of nuclear factor-E2-related factor (Nrf2) binding to MRP4 promoter. Dual-luciferase reporter assaywas used to detect the binding of tumor necrosis factor α (TNFα) to the promotor of E2F1. The bile duct ligation mouse models wereestablished using male C57BL/6 mice. Results: The mRNA and protein levels of MRP4 were significantly increased in cholestatic patients. TNFα treatment induced theexpression of MRP4 and Nrf2 and enhanced cell nuclear extract binding activity to MRP4 promoter, as demonstrated by EMSA. Nrf2knockdown reduced MRP4 mRNA levels in both HepG2 and Hep-3B cells. In addition, TNFα increased Rb phosphorylation and expressionof MRP4 and Nrf2 and activated E2F1 and phosphorylated p38 in HepG2 and Hep-3B cells. These effects were markedly inhibitedby pretreatment with E2F1 siRNA. Dual-luciferase reporter assay validated that TNFα induces the transcription of E2F1. Furthermore,the expression of MRP4, Nrf2, E2F1, and p-p38 proteins was improved with treatment of TNFα in a mouse model ofcholestasis. E2F1 siRNA lentivirus or SB 203580 (p38 inhibitor) inhibited these positive effects. Conclusion: Our findings indicated that TNFα induces hepatic MRP4 expression through activation of the p38-E2F1-Nrf2 signalingpathway in human obstructive cholestasis.

Abstract

Purpose: To explore the molecular mechanism of the upregulation of multidrug resistance-associated protein 4 (MRP4) in cholestasis. Materials and Methods: The mRNA and protein levels of MRP4 in liver samples from cholestatic patients were determined byquantitative real-time PCR and Western blot. In human hepatoma HepG2 cells, electrophoretic mobility shift assay (EMSA) wasused to determine the affinity of nuclear factor-E2-related factor (Nrf2) binding to MRP4 promoter. Dual-luciferase reporter assaywas used to detect the binding of tumor necrosis factor α (TNFα) to the promotor of E2F1. The bile duct ligation mouse models wereestablished using male C57BL/6 mice. Results: The mRNA and protein levels of MRP4 were significantly increased in cholestatic patients. TNFα treatment induced theexpression of MRP4 and Nrf2 and enhanced cell nuclear extract binding activity to MRP4 promoter, as demonstrated by EMSA. Nrf2knockdown reduced MRP4 mRNA levels in both HepG2 and Hep-3B cells. In addition, TNFα increased Rb phosphorylation and expressionof MRP4 and Nrf2 and activated E2F1 and phosphorylated p38 in HepG2 and Hep-3B cells. These effects were markedly inhibitedby pretreatment with E2F1 siRNA. Dual-luciferase reporter assay validated that TNFα induces the transcription of E2F1. Furthermore,the expression of MRP4, Nrf2, E2F1, and p-p38 proteins was improved with treatment of TNFα in a mouse model ofcholestasis. E2F1 siRNA lentivirus or SB 203580 (p38 inhibitor) inhibited these positive effects. Conclusion: Our findings indicated that TNFα induces hepatic MRP4 expression through activation of the p38-E2F1-Nrf2 signalingpathway in human obstructive cholestasis.

참고문헌 (30)

  1. Miszczuk GS, "Adaptive downregulation of Cl-", HCO3-exchange activity in rat hepatocytes under experimental obstructive cholestasis, 2019, pp.14, e0212215~
  2. Wagner M, "Transcriptional regulation of hepatobiliary transport systems in health and disease : implications for a rationale approach to the treatment of intrahepatic cholestasis", Ann Hepatol, 4, pp.77~99 (2005)
  3. Zollner G, "Role of nuclear receptors in the adaptive response to bile acids and cholestasis : pathogenetic and therapeutic considerations", Mol Pharm, 3, pp.231~251 (2006)
  4. Wagner M, "New molecular insights into the mechanisms of cholestasis", J Hepatol, 51, pp.565~580 (2009)
  5. Schuetz JD, "MRP4 : a previously unidentified factor in resistance to nucleoside-based antiviral drugs", Nat Med, 5, pp.1048~1051 (1999)
  6. Borst P, "Mammalian ABC transporters in health and disease", Annu Rev Biochem, 71, pp.537~592 (2002)
  7. Wielinga PR, "Characterization of the MRP4-and MRP5-mediated transport of cyclic nucleotides from intact cells", J Biol Chem, 278, pp.17664~17671 (2003)
  8. Schuetz EG, "Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450", J Biol Chem, 276, pp.39411~39418 (2001)
  9. Wagner M, "Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice", Gastroenterology, 125, pp.825~838 (2003)
  10. Donner MG, "Obstructive cholestasis induces TNF-alpha-and IL-1-mediated periportal downregulation of Bsep and zonal regulation of Ntcp, Oatp1a4, and Oatp1b2", Am J Physiol Gastrointest Liver Physiol, 293, pp.G1134~46 (2007)
  11. Stedman CA, "Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury", Proc Natl Acad Sci U S A, 102, pp.2063~2068 (2005)
  12. Petrick JS, "Importance of hepatic induction of constitutive androstane receptor and other transcription factors that regulate xenobiotic metabolism and transport", Drug Metab Dispos, 35, pp.1806~1815 (2007)
  13. Chen P, "Low dose of oleanolic acid protects against lithocholic acid-induced cholestasis in mice : potential involvement of nuclear factor-E2-related factor 2-mediated upregulation of multidrug resistance-associated proteins", Drug Metab Dispos, 42, pp.844~852 (2014)
  14. Bohan A, "Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3)reduces liver injury in obstructive cholestasis", J Biol Chem, 278, pp.36688~36698 (2003)
  15. Chai J, "Elevated hepatic multidrug resistance-associated protein 3", ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase, Hepatology, pp.2012, 55[DOI]
  16. Zhang FX, "Bacterial lipopolysaccharide activates nuclear factor-kappaB through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes", J Biol Chem, 274, pp.7611~7614 (1999)
  17. Lee J, "Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat", Gastroenterology, 121, pp.1473~1484 (2001)
  18. Chai J, "Changes of organic anion transporter MRP4 and related nuclear receptors in human obstructive cholestasis", J Gastrointest Surg, 15, pp.996~1004 (2011)
  19. Renga B, "Farnesoid X receptor suppresses constitutive androstane receptor activity at the multidrug resistance protein-4 promoter", Biochim Biophys Acta, 1809, pp.157~165 (2011)
  20. Chai J, "Canalicular membrane MRP2", ABCC2 internalization is determined by Ezrin Thr567 phosphorylation in human obstructive cholestasis, 2015, pp.63, 1440~1448
  21. Denk GU, "Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the rat", J Hepatol, 40, pp.585~591 (2004)
  22. Geier A, "Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration", Biochim Biophys Acta, 1773, pp.283~308 (2007)
  23. Osawa Y, "Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1production in hepatic stellate cells", PLoS One, 8, pp.e65251~ (2013)
  24. Nagaki M, "Tumor necrosis factor alpha prevents tumor necrosis factor receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated apoptosis : role of nuclear factor-kappaB", Hepatology, 32, pp.1272~1279 (2000)
  25. Malekshah OM, "PXR and NF-κB correlate with the inducing effects of IL-1β and TNF-αon ABCG2 expression in breast cancer cell lines", Eur J Pharm Sci, 47, pp.474~480 (2012)
  26. Eba S, "The nuclear factor erythroid 2-related factor 2 activator oltipraz attenuates chronic hypoxia-induced cardiopulmonary alterations in mice", Am J Respir Cell Mol Biol, 49, pp.324~333 (2013)
  27. Trimarchi JM, "Sibling rivalry in the E2F family", Nat Rev Mol Cell Biol, 3, pp.11~20 (2002)
  28. Wang S, "Regulation of Rb and E2F by signal transduction cascades : divergent effects of JNK1and p38 kinases", EMBO J, 18, pp.1559~1570 (1999)
  29. Whyte-Allman SK, "Xenobiotic nuclear receptors pregnane X receptor and constitutive androstane receptor regulate antiretroviral drug efflux transporters at the blood-testis barrier", J Pharmacol Exp Ther, 363, pp.324~335 (2017)
  30. Soroka CJ, "Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver", Hepatology, 33, pp.783~791 (2001)

관련 논문AI추천

Taurocholic acid promotes hepatic stellate cell activation via S1PR2/p38 MAPK/YAP signaling under cholestatic conditionsJing Yang, Lixin Sun, Mingzhu Chen, Xujiao Tang, Zhu Liang대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Alteration of Bile Acid Transporter Expression in Patients with Early Cholestasis Following Living Donor Liver Transplantation김동구, 김병기, 김소윤, 박영민, 배시현, 윤승규, 이연수, 정은선, 최종영대한병리학회 · Journal of Pathology and Translational Medicine2009 · 제43권 제1호Sestrin2 protects against cholestatic liver injury by inhibiting endoplasmic reticulum stress and NLRP3 inflammasome-mediated pyroptosis박환우, 신종대, 한경호, Bae Jeongyun, Han Daewon, Han Seung Yun, Kang Hyun-Goo, Kim Haeil, Kim Soojin, Le Qui Anh, Shin Hye Won생화학분자생물학회 · Experimental and Molecular Medicine2022 · 제54권 CO/HO-1 Induces NQO-1 Expression via Nrf2 Activation김슬기, 김효정, 신창호, 정헌택, 조연수, 조정지, Min Zheng대한면역학회 · Immune Network2011 · 제11권 제6호Elk-3 Contributes to the Progression of Liver Fibrosis by Regulating the Epithelial-Mesenchymal Transition김성민, 김정희, 윤승규, 이은별, 이준호, 이천주, 최정은, 허원희, 홍성우거트앤리버 소화기연관학회협의회 · Gut and Liver2017 · 제11권 제1호Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways고동희, 노윤진, 이승민, Dae Won Jun, Hyeon Tae Kang, Hyunsung Kim, Ju Hee Oh대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제4호

이 간행물의 다른 논문 (7건)